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ABSTRACT
Cell fate transitions in mammalian stem cell systems have often been associated with transcrip-
tional heterogeneity; however, existing data have failed to establish a functional or mechanistic
link between the two phenomena. Experiments in unicellular organisms support the notion that
transcriptional heterogeneity can be used to facilitate adaptability to environmental changes
and have identified conserved chromatin-associated factors that modulate levels of transcrip-
tional noise. Herein, we show destabilization of pluripotency-associated gene regulatory net-
works through increased transcriptional heterogeneity of mouse embryonic stem cells in which
paradigmatic histone acetyl-transferase, and candidate noise modulator, Kat2a (yeast orthologue
Gcn5), have been inhibited. Functionally, network destabilization associates with reduced pluri-
potency and accelerated mesendodermal differentiation, with increased probability of transi-
tions into lineage commitment. Thus, we show evidence of a relationship between
transcriptional heterogeneity and cell fate transitions through manipulation of the histone acety-
lation landscape of mouse embryonic stem cells, suggesting a general principle that could be
exploited in other normal and malignant stem cell fate transitions. STEM CELLS 2018;
36:1828–1838
SIGNIFICANCE STATEMENT
Pluripotent mouse embryonic stem cells (mESCs) are capable of differentiating toward all
mature cell types through cell fate transition events, which are often associated with increased
transcriptional heterogeneity. Yet, there is little understanding of the molecular mechanisms
underlying this phenomenon. Through inhibition of the histone acetyltransferase Kat2a in
pluripotent mESCs, an increase in transcriptional heterogeneity (as measured by coefficient of
variation) and an increased probability of exit from pluripotency is observed. The results of this
study suggest the existence of an important relationship between chromatin modification, tran-
scriptional heterogeneity, and cell fate decisions, which is likely to be important in understand-
ing development and disease.
INTRODUCTION
Cellular states, and their associated transi-
tions, are a function of the transcriptional
programs active in the cell, which in turn
depend on the chromatin configuration of
their respective genes. It has been observed
in multiple mammalian differentiation and
developmental systems, including in mouse
embryonic stem (ES) cells, that the cellular
states during transition events are heteroge-
neous at the transcriptional level [1–7]. Such
heterogeneity is thought to reflect temporal
variability in gene expression, within individ-
ual cells, in an uncoordinated manner [8].
When variability affects genes that are
regulators or effectors of cell fates, the
expression status of individual genes can
endow cells with different probabilities of
effecting a transition [9], eventually resulting
in a proportion of cells acquiring the new fate;
thus, heterogeneity in expression of these
genes would vary the transition probability
from a given state.
The homeobox gene Nanog is a paradig-
matic pluripotency regulator that exhibits such
variability in gene expression [10–12]. Nanog is
strictly required for establishment of pluripo-
tency, both in vitro and in the embryo [13], but
is dispensable for its maintenance [11]. Nanog
transcriptional reporters have been used to
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expression levels and, while there is some reversibility between
Nanog high and low expression states, Nanog low cells have a
higher probability of exiting self-renewal into differentiation
[10, 12]. A role of Nanog down-regulation in the probabilistic
exit from pluripotency is supported by experiments coupling
reversible Nanog knockdown with single-cell transcriptomics
showing that remodeling of pluripotency networks associated
with Nanog loss can be transiently reversed [14].
The Nanog transcriptional reporters that are based on sta-
ble green fluorescent protein (GFP; heterozygous TNGA cells)
[11] exhibit a trimodal distribution of high, mid and low GFP
populations. While the high and low states represent the active
and inactive transcriptional state of Nanog, respectively, the
mid-Nanog (MN) population is likely to contain cells in which
the Nanog promoter has been recently switched off, reversibly
or irreversibly, causing the GFP levels to decay. This population
is less apparent in destabilized fluorescent reporters such as
the destabilized Venus reporter line, Nanog-venus-nuclear
localization signal-pEST degradation signal (VNP) [15], confirm-
ing that intermediate levels of expression are not sustainable
and resolve rapidly into high (HN) or low (LN) states. Therefore,
in theory, the MN population should encompass all bona fide
early transition events out of pluripotency and into lineage
commitment. However, its transient nature makes it difficult to
probe the molecular programs of the state transition separate
from protracted GFP expression, or confounding dissociation
between reporter and endogenous Nanog expression [16].
Assessing the mechanistic basis of the transition out of
pluripotency can be finely achieved through the use of Nanog
reporter systems and it may shed light on a putative contribu-
tion of transcriptional heterogeneity to the probabilistic nature
of cell state transitions. Dynamic changes in transcriptional
activity, and the resulting changes in state-transition probabili-
ties, are likely to be regulated, at least in part, at the level of
histone lysine acetylation. In yeast, amplitude and frequency
of transcriptional bursting [17] are regulated by distinct his-
tone acetyl-transferase and deacetylase complexes which
determine levels of H3K9 acetylation (H3K9ac) in the promoter
and the body of the gene [18]. Promoter acetylation influences
transcriptional variability or noise, as measured by coefficient
of variation (CV = standard deviation/mean). Loss of the his-
tone acetyl-transferase Gcn5 or its partner Sgf29 result in
increased noise, while loss of components of the Rdp3s his-
tone deacetylase (HDAC) complex, which increase levels of
H3K9ac, reduce gene expression CV.
To achieve a global reduction of H3K9ac in mouse ES
cells, we chemically inhibited Gcn5 with the (2R,3S)-rel-4-
Methylene-5-oxo-2-propyltetrahydrofuran-3-carboxylic acid
(MB-3) compound [19], which we have recently validated to
phenocopy loss of Gcn5 homolog KAT2A in mammalian cells
[20]. While this resulted in minimal changes to average gene
expression levels, it caused a significant enhancement of
expression heterogeneity for a number of genes, including
Nanog, with associated remodeling of gene regulatory net-
works (GRNs). These changes associated with functional
destabilization of pluripotency and accelerated differentia-
tion, namely to mesendodermal (ME) lineages. Our results
suggest that increased transcriptional heterogeneity may not
only reflect but indeed mechanistically promote state transi-
tions in mammalian cells.
MATERIALS AND METHODS
Cell Culture
E14Tg2A, TNGA [11], Nanog-VNP [15], Sox1-GFP [21], and T-
GFP [22] mouse ES cells were maintained or differentiated as
described [23]. 2i medium used N2B27 (NDiff 227, Takara,
Saint-Germain-en-Laye, France) with 1 μM PDO325901 (R&D,
Abingdon, UK) and 3 μM Chiron (Cambridge Wellcome Trust/
Medical Research Council Stem Cell Institute). Kat2a inhibition
used 100 μM MB-3 (ab141255, AbCam, Cambridge, UK) [19],
or an equal volume of dimethyl sulfoxide (DMSO). ES cell
colony-forming capacity was quantified using Alkaline Phospha-
tase detection kit (Sigma Aldrich, Gillingham, UK) as per manu-
facturer’s instructions.
Flow Cytometry
Cell sorting was done on MoFlo (Beckman Coulter, High
Wycombe, UK), FACSAria III (BD, Wokingham, UK), or Influx
(BD) machines, and analysis performed on a BD LSR-Fortessa,
with 40,6-diamidino-2-phenylindole (DAPI) as a dead cell
marker. Apoptosis analysis used Annexin-V antibody (a13202
Fluor-568, Invitrogen, Loughborough, UK) and DAPI as per
manufacturers’ instructions. Cell cycle analysis used Propidium
Iodide staining of ethanol-fixed cells.
Wash-Off Experimental Protocol
TNGA cells in serum and leukemia inhibitory factor, LIF (ESLIF)
were grown for 1 or 2 days with DMSO or MB-3 (50 and
100 μM), or exposed to control N2B27 pro-differentiation con-
ditions. At the end of the treatment, cells were washed of the
treatment, their GFP profile assessed, and cultured for up to
5 days in ESLIF with daily monitoring of distribution of GFP
levels (Supporting Information Fig. S3A). The composite GFP
distribution obtained from randomly sampled cells from all
time-points and conditions was best described by three Gauss-
ian curves that correspond to the HN, MN, and LN states [24]
(Supporting Information Fig. S3B), and every cell was assigned
to one of these states using a probabilistic soft clustering
approach (see Supporting Information Data). Population pro-
portions were calculated for each condition at each time point,
and kinetic modeling used to estimate rates of transition
between states and general state reversibility (Fig. 3B, 3C).
RNA Sequencing
RNA extracted from TNGA cells treated in triplicate for 48 hours
in ESLIF with DMSO or MB-3 (100 μM), was used for polyA
library preparation and sequencing on an Illumina HiSeq4000
instrument (Illumina, Cambridge, UK). Details of alignment,
quantification, differential gene expression and data analysis
are described in Supporting Information Data. Data have been
deposited in GEO (GSE114797).
Chromatin Immunoprecipitation Sequencing
Chromatin was prepared from TNGA cells treated in duplicate
for 48 hours in ESLIF with DMSO or MB-3 (100 μM), and
immunoprecipitated with an anti-H3K9ac antibody (ab4441,
AbCam), as described [20]. Details of alignment, peak calling
and identification, and data analysis are described in detail in
Supporting Information Data. Data have been deposited in
GEO (GSE114797).
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Single-Cell Quantitative Reverse Transcription
Polymerase Chain Reaction
Single-cell quantitative reverse transcription polymerase chain
reaction (scRT-qPCR) followed the Fluidigm Two-Step Single-
Cell Gene Expression method on a 96.96 Dynamic Array IFC
and the BioMark HD system (Fluidigm, London, UK), with Eva-
Green Supermix [25] (primers in Supporting Information
Table S1) or Taqman Assays (Supporting Information Table S2).
Commercially available spike-ins (Fluidigm, C1 RNA Standards
Assay Kit, PN100-5582) controlled for technical variability.
Further details of analysis are described in Supporting
Information Data.
RESULTS
Kat2a Inhibition in Mouse ES Cells Decreases H3K9ac
and Enhances Heterogeneity of Nanog Expression
We treated TNGA cells with MB-3 and observed a global
reduction of H3K9ac both in number and height (Fig. 1A) of
acetylation peaks. As expected for H3K9ac mark, the large
majority of peaks were located in the vicinity of transcriptional
start sites (TSS) (Fig. 1B), and the regions in which acetylation
was lost as a result of MB-3 treatment were significantly
enriched for Kat2a/Gcn5 occupancy as per the ENCODE signifi-
cance tool (Fig. 1C), supporting specificity of MB-3 activity.
Myc/Max and E2F binding was also enriched at these loca-
tions, highlighting their well-described cooperation with Kat2a
[26, 27]. The loci specifically affected by Kat2a inhibition
(Supporting Information Files S1 and S2) associated with meta-
bolic functions, namely mitochondrial, as well as DNA and RNA
metabolism (Supporting Information File S3), suggesting an
impact on general, rather than tissue-specific, functions and
putative pervasive activities across multiple cell types. Interest-
ingly, the overall reduction in H3K9ac did not translate into
substantial changes in gene expression (Fig. 1D), as RNA
sequencing (RNA-seq) analysis of MB-3 versus DMSO (vehicle)-
treated TNGA cells revealed 599 differentially expressed genes,
with only 3 at a fold change ≥2 (Supporting Information File
S4). Differentially expressed genes showed overlap with genes
with differential H3K9ac and were significantly enriched in
Kat2a binding targets (Fig. 1E), namely those recently
described in mouse ES cells [26] (Fig. 1F). Given that the
reduction in H3K9ac was not matched by significant changes in
gene expression levels, we asked whether treatment might
instead result in enhanced cell-to-cell heterogeneity of tran-
scription, as described for Gcn5 in yeast.
We selected a representative subset of Kat2a binding tar-
gets, using the Hirsch et al. dataset to identify 47 targets of
interest, and interrogated 70 individual cells (35 DMSO,
35 MB-3) for transcript levels and cell-to-cell transcriptional
variability (measured by CV), using scRT-qPCR. Similar to the
RNA-seq data, we did not find significant differences in mean
expression levels between the two treatments (Fig. 1G). How-
ever, for the majority of the individual genes analyzed, as well
as at a global level, there was a significant increase in CV
(Fig. 1H). The data thus support the hypothesis that inhibition
of Kat2a-dependent H3K9ac results in increased transcriptional
heterogeneity in mouse ES cells, similarly to previous observa-
tions in Saccharomyces cerevisiae (supporting information data
of [18]).
We then focused on components of the pluripotency net-
work and asked whether their H3K9ac status was affected by
Kat2a inhibition. We found that individual H3K9ac peaks were
lost in the proximal upstream regions of the Pou5f1/Oct4 locus
[28] upon MB-3 treatment (Fig. 2A), an observation that
extended to its regulator Sall4 [30](Supporting Information File
S2). Furthermore, we observed a reduction in H3K9ac in the
Nanog locus (Fig. 2A), including at a distal H3K9ac-enriched
region which might correspond to an enhancer element [31].
The impact on Nanog prompted us to check whether Kat2a
inhibition with MB-3-affected heterogeneity of GFP expression
in TNGA cells, which has been associated with altered likeli-
hood of pluripotency and differentiation state transitions [24].
Indeed, sustained inhibition of Kat2a activity modified GFP
expression from the Nanog locus, with increased representa-
tion of MN cells and a broader distribution of fluorescence
intensity values, distinct from the dominant HN observed in
control cells (Fig. 2B). A similar increase in Nanog expression
heterogeneity could be reproduced in wild-type E14tg2A
mouse ES cells using immunofluorescence staining of endoge-
nous NANOG protein (Fig. 2C), suggesting that the results were
not limited to the TNGA genetic background.
Knockdown of Kat2a expression, through lentiviral-
delivered short hairpin RNAs, supports the specificity of inhibi-
tor activity. Kat2a depletion in TNGA cells increases heteroge-
neity in the distribution of Nanog levels in a manner
proportional to the level of Kat2a knockdown, with accumula-
tion of MN and LN cells (Supporting Information Fig. S1A). Sim-
ilar results are obtained in the Nanog-VNP cell line [15]
(Supporting Information Fig. S1B), in which MB-3 treatment
also results in a shift toward lower Nanog levels (Supporting
Information Fig. S1C). Overall, the results indicate that loss of
Kat2a activity impacts variability of Nanog expression in a man-
ner suggestive of enhanced transition out of pluripotency, as
represented by high Nanog levels. We pursued these findings
at a functional level to determine the associated impact on
cellular state.
Kat2a Inhibition Impacts Mouse ES Cell Pluripotency
and Differentiation
We tested the functional impact of Kat2a inhibition on pluripo-
tency by treating TNGA, E14tg2a, and Nanog-VNP cells with MB-3
or DMSO in conventional serum and LIF-containing culture condi-
tions (ESLIF; Fig. 3A). After 1–3 days of treatment, we washed off
the inhibitor, and cultured the cells under stringent naïve pluripo-
tency “2i” conditions [32], after which we quantified the number
of undifferentiated alkaline phosphatase-positive colonies
obtained. While DMSO exposure had no effect on colony forma-
tion, cells exposed to MB-3 gradually lost the capacity to establish
pluripotent colonies (Fig. 3B), compatibly with an increased prob-
ability of exiting the pluripotent state. In agreement with these
findings, TNGA cells newly cultured in 2i conditions from ESLIF
routine culture, in the presence of MB-3, show a broader GFP
peak (Supporting Information Fig. S2A), which is lost as cells
undergo increased apoptosis (Supporting Information Fig. S2B),
presumably because of the inability of 2i medium to sustain
primed and committed states. Cells cultured in ESLIF, conversely,
do not show increased apoptosis (Supporting Information
Fig. S2B), and their cell cycle status is also not affected
(Supporting Information Fig. S2C). Interestingly, cells adapted to 2i
conditions over several passages are unaffected by Kat2a
©2018 The Authors Stem Cells published by
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inhibition by 2i + MB-3 treatment (Supporting Information
Fig. S2D), which may reflect a change of epigenetic control, and is
not dissimilar to loss of Nanog itself in mouse ES cells.
We then asked if Kat2a inhibition promoted differentiation
decisions. We took advantage of ES cells with a GFP reporter
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Figure 1. Effects of Kat2a inhibition on H3K9ac and transcriptional heterogeneity of mouse embryonic stem (ES) cells. (A): MB-3 treat-
ment of TNGA mouse ES cells results in specific loss of H3K9ac. Height and number (DMSO: 11724; MB-3: 4673, 98% overlap) of H3K9ac
peaks are significantly reduced after 2 days of MB-3 treatment. (B): H3K9ac marks associated with TSS maintain their location profiles fol-
lowing MB-3 treatment but reduce in number. (C): Transcription factor binding sites associated with genes that display reduced H3K9ac
following MB-3 treatment include GCN5/Kat2a. List represents transcription factors with Q-value equal to 0, ordered by proportion of
observed H3K9ac differential genes to total number of binding site-associated genes. (D): RNA-seq analysis of TNGA mouse ES cells trea-
ted with MB-3 for 2 days. Volcano plot highlighting differentially expressed genes (red dots: adjusted p-value <.05). (E): Differentially
expressed genes partially overlap with H3K9ac gene-associated peaks lost on MB-3 treatment. (F): Gene set enrichment analysis of Kat2a
direct targets in mouse ES cells among MB-3 down-regulated genes (ES = −0.30, NES = −1.34; p value = .005). The negative enrichment
score of direct targets (top panel) along the differential RNA-seq dataset ordered by rank (bottom panel) reveals that it is the down-
regulated genes on MB-3 treatment that are most enriched for Kat2a direct targets. (G): Quantification of mean gene expression from
Single-cell quantitative reverse transcription polymerase chain reaction (scRT-qPCR) from cells treated with DMSO or MB-3. There is no
significant difference in mean gene expression between these conditions (Student’s t test, p > .05). (H): CV of genes following scRT-qPCR
shows increase in CV on MB-3 treatment (Student’s t test, p < .01). Abbreviations: CV, coefficient of variation; DMSO, dimethyl sulfoxide;
GSEA, gene set enrichment analysis; TSS, transcriptional start sites.
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periods of time in the presence of DMSO or MB-3 before
washing-off the treatment and placing the cells under ME-
promoting culture conditions (Fig. 4A). We observed a signifi-
cant acceleration of T expression in cells exposed to MB-3
(Fig. 4B). The same, however, was not true of Sox1-GFP [33]
expression in ES cells placed under neuro-ectodermal
(NE) culture conditions after inhibitor treatment (Supporting
Information Fig. S2E), suggesting some selectivity in lineage
commitment decisions.
Kat2a Inhibition Captures a MN Transition State in
Mouse ES Cells
The impact of MB-3 treatment on pluripotency and ME differ-
entiation is suggestive of a change in the probability of state
transition, rather than with an absolute requirement to either
anti-NANOG Fluorescence Intensity [Log10] (a.u.) 
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Figure 2. Effect of Kat2a inhibition on Nanog transcriptional het-
erogeneity. (A): Chromatin immunoprecipitation analysis of H3K9
acetylation at the Pou5f1 (top) and Nanog (bottom) loci, showing
reduction in height and peak width/number upon MB-3 treat-
ment. There is specific loss of H3K9ac at the Pou5f1 promoter
immediately upstream of exon E1 included in the pluripotency-
associated Oct4a transcript and protein isoform [29]. (B): Flow
cytometry analysis of heterozygous GFP expression from the
Nanog locus in TNGA cells upon 1–3 days of MB-3 treatment; data
representative greater than five independent observations. (C):
Equivalent increase in heterogeneity observed in wildtype E14tg2A
cells stained with NANOG antibody (see Supporting Information
Methods for quantification details). Abbreviations: CV, coefficient















Figure 3. Effects of MB-3 treatment on naïve pluripotency. (A):
Experimental design: TNGA cells treated with MB-3 or DMSO in
ESLIF (1–3 days), followed by passaging at clonal density and cul-
ture in 2i medium for 7 days. Pluripotency measured by colony
number and alkaline phosphatase (AP) staining in colonies, as
shown in representative images below. (B): Significantly reduced
number of AP+ pluripotent colonies from MB-3-treated cells after
2i medium switch (n = 3; Student’s t test, p < .05). No significant
difference was observed in frequencies of mixed or differenti-
ated colonies (data not shown). Abbreviation: DMSO, dimethyl
sulfoxide.
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state. To measure the probability of ES cells moving from pluri-
potency toward priming and commitment and the reversibility
of these transitions, we used the TNGA cells and modeled
rates of transition between HN (pluripotent), MN (primed),
and LN (committed) states upon treatment exposure and
wash-off (Fig. 5A; see section for details).
DMSO-treated cells were unchanged by the treatment and
transited between HN and MN states with a slight advantage
toward the reverse movement, sustaining a dominant HN pop-
ulation. N2B27-treated cells showed a clear movement toward
the LN state, denoting irreversible differentiation, which was
dependent on the duration of treatment. MB-3-treated cells
displayed a unique pattern of long-term retention in the MN
state, with slow transition rates in either direction and a pro-
gressive dose and time-dependent decrease in reversibility
(Fig. 5B, 5C and Supporting Information Fig. S3A, S3B). A simi-
lar pattern was observed in TNGA sorted as MN and exposed
to MB-3 (Supporting Information Fig. S3C). Overall, the data
suggest that inhibition of Kat2a-mediated acetylation permits
the capture of mouse ES cells at the exit of pluripotency; in
doing so, it may enrich for an otherwise fleeting state of tran-
sition out of pluripotency and into early ME differentiation.
MB-3-Driven Pluripotency-To-ME Transition Associates
with Transcriptional Heterogeneity
We next sought to characterize the transcriptional architecture
of the transition state at single-cell resolution by interrogating
individual cells captured from MB-3 and DMSO-treated cul-
tures of mouse TNGA ES cells. We used scRT-qPCR transcrip-
tional profiling and determined the presence, level, and
heterogeneity of expression of a selection of 92 genes with
roles in ES cell pluripotency and differentiation (Supporting
Information Fig. S4A). We excluded LN cells to avoid the con-
founding effect of irreversibly committed or differentiated
cells, and analyzed 90 TNGA cells from ESLIF cultures, which
are permissive to priming, and 138 from recently established
naïve 2i cultures, which respond to MB-3 treatment with a
broadened peak of GFP fluorescence intensity (Supporting
Information Fig. S2A), but do not sustain priming of differenti-
ation programs. Global representation of the transcriptional
programs of individual TNGA cells under the different experi-
mental conditions shows an evident separation between the
transcriptional spaces occupied by naïve and primed pluripo-
tency. Importantly, it also reveals that the transcriptional space
occupied by MB-3-treated 2i cells is in closer proximity to
primed pluripotency than control (DMSO-treated) 2i cells
(Fig. 6A), suggesting a requirement for Kat2a activity in estab-
lishing or maintaining pluripotency. This is consistent with the
findings of Dent and colleagues [26], who identified a require-
ment for Kat2a in coordination with Myc in establishing
induced pluripotency upon reprograming of differentiated
somatic cells. In contrast, Kat2a active and inactive primed
pluripotency transcriptional landscapes are closely overlapping
(Fig. 6A), which may partly reflect the exclusion of cells with
lower levels of Nanog, and also denote the slow transit of MB-
3 treated cells out of the primed self-renewal (Supporting
Information Fig. S3B).
We inspected the specific changes in single-cell gene
expression patterns imposed by MB-3 treatment which under-
lay a misconfiguration of the 2i transcriptional state. We noted
that MB-3 treated cells in naïve pluripotent conditions signifi-
cantly enhanced cell-to-cell variability, or heterogeneity, of
gene expression levels relative to control (Fig. 6B and Support-
ing Information File S5), a finding reminiscent of the role of
Kat2a yeast homolog Gcn5 in transcriptional noise [34]. A simi-
lar significant gain of gene expression variability was also
observed in primed cells upon MB-3 treatment (Fig. 6B and
Supporting Information File S5). Increased heterogeneity
occurred at all levels of average gene expression (Supporting
Information Fig. S4B), and with no significant change to aver-
age gene expression levels (Fig. 6C and Supporting Information
Fig. S4D). Frequency of gene expression was more dynamic
between conditions, with minimal changes in ES-LIF, and some
significant gains and losses in 2i in the presence of MB-3
(Supporting Information Fig. S4C). We did not observe the
presence of new cell clusters within ES-LIF or 2i cultures upon
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Figure 4. Effect of MB-3 treatment on mesendodermal differen-
tiation of mouse embryonic stem (ES) cells. (A): Mesendodermal
differentiation experimental design: Brachyury-GFP (T-GFP) cells
treated with MB-3 or DMSO in ESLIF medium (1–2 days) before
wash-off and replating in N2B27 (days 0–1) followed by N2B27
with 100 ng/ml Activin and 3 μM Chiron (days 2–4). Flow cytome-
try was used to quantify the proportion of GFP+ cells on days 1–4
of differentiation. (B): Exposure of mouse ES cells to MB-3 for
2 days significantly anticipates detection of T-GFP expression,
indicative of accelerated ME commitment (n = 4). Paired Student’s
t test. *p < .05. Abbreviations: DMSO, dimethyl sulfoxide; GFP,
green fluorescent protein.
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MB-3 treatment (Supporting Information Fig. S4E), suggesting
that the observed gain in heterogeneity upon Kat2a inhibition
results from transcriptional perturbation and does not arise
from the de novo emergence of new cell populations. We
sought to articulate changes in gene expression frequency and
variability of transcript levels through inference of GRNs, to
understand the contribution of transcriptional heterogeneity
to regulatory programs at the exit of pluripotency.
MB-3-Driven Reconfiguration of GRNs Is Centered on
Noise and H3K9ac Changes
We focused on control and MB-3 treated cells in 2i culture
conditions, where the transcriptional distance between states
is more notable, and attempted to infer GRNs through a com-
bination of binary and correlation methods we recently used
in an adult differentiation system [35] (Supporting Information
File S6). Given the proposed association from our data
between loss of Kat2a-dependent H3K9ac and gene expression
variability, we asked if this phenomenon might be instrumental
in reconfiguring GRNs. Reassuringly, the inferred control net-
work was strongly nucleated in pluripotency factor Oct4/
Pou5f1 (Fig. 7A), as well as in Wnt signaling elements Ctnnb
and Cdh1, which likely reflect GSK-dependent Wnt activation
in 2i culture conditions. Upon MB-3 treatment, we observed a
specific reduction of network connectivity amongst nodes
dependent on Kat2a activity for H3K9ac (Fig. 7B). Pluripotency
regulators Pou5f1 and Sall4, as well as Jarid2 showed complete
loss of connectivity upon Kat2a inhibition, while the network
around Cdh1 was greatly reduced (Fig. 7A, 7B). Importantly,
when focusing on remodeled edges built around the
















































































































3-state model with 3 Ordinary Differential 
Equations and 4 Rate Constants
Treatment and Duration (Days Treated)
Days































1 2 3 4
N2B27 1DT
Days
1 2 3 4
DMSO 2DT
Days
1 2 3 4
100uM MB-3 1DT
Days
1 2 3 4
N2B27 2DT
Days
1 2 3 4
B
Figure 5. Inhibition of Kat2a catalytic activity affects reversibility of commitment decisions in TNGA mouse embryonic stem cells. (A):
Experimental design of wash-off experiments (left) and modeling approach (right). TNGA cells were cultured for 1–2 days in ESLIF medium
with MB-3 (50 or 100 μM) or DMSO, or in N2B27 differentiation medium. Cells were washed off the treatment, and cultured for up to
3 days in ESLIF, with daily monitoring of Nanog-GFP profile. Four independent biological replicas were performed for accurate model fit-
ting. A model was constructed using the proportion of cells in each of the three HN, MN, and LN states with four kinetic parameters
(A1-4; see Supporting Information Methods). (B): Proportion of cells assigned to each state (HN, MN, or LN) on each day of the protocol,
per treatment. (C): Kinetic modeling of transition rates between HN, MN, and LN states in response to transient exposure to MB-3
(DMSO or N2B27, controls). HN-to-MN represents exit from pluripotency/commitment to differentiate; MN-to-LN represents differentia-
tion; reversibility of either decision is given by the reverse transition probability. (D): Reversibility indices (MN-to-HN + LN-to-MN)/(HN-to-
MN + MN-to-LN) for different doses and durations of treatment. Green text indicates equivalent percentage of DMSO treatment.
Abbreviations: DMSO, dimethyl sulfoxide; DT, days treatment; GFP, green fluorescent protein; HN, high Nanog-GFP; MN, mid Nanog-GFP;
LN, low Nanog-GFP.
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respiratory chain component Ndufa9 and differentiation factor
Mff, both H3K9ac differential targets, we observed that the
new connections established upon MB-3 treatment were with
genes presenting significantly higher CV gains relative to non-
remodeled edges (Fig. 7C); as a trend, gains in CV were also
higher relative to edges exclusively detected in DMSO-treated
cultures. A similar pattern of higher CV gains upon Kat2a inhi-
bition was not observed in remodeled edges around nodes not
strictly dependent on Kat2a for H3K9ac (Fig. 7D), suggesting a
direct contribution to locus regulation. Furthermore, in interro-
gating the networks for genes exclusively connected upon
Kat2a inhibition, we found that these presented higher CV
gains than those genes exclusively present in the control net-
work (Fig. 7E), suggesting a role for noise in network mainte-
nance and reconfiguration.
The nature of the genes unique to each network underlies
the phenotypes observed. In addition to Pou5f1, Sall4, and
Jarid2, the control network uniquely also includes Fgf signaling
elements, recently reported to be regulated by Kat2a [27], and
Id3, a BMP target [21]. Amongst the nodes specific to the MB-
3 network are endodermal (Afp), mesodermal (Chrd, Wnt3a)
and NE (Dmbx1, Evx1) differentiation genes. Interestingly, the
MB-3 network also uniquely includes Nanog, whose presence
in the network may reflect capture of the proposed early tran-
sition state into commitment (Fig. 5 and Supporting Informa-
tion Fig. S3). Overall, our data support the notion that
MB-3-mediated loss of H3K9ac at target loci critically reconfi-
gures the architecture of the GRN sustaining pluripotency,
through a direct effect on variability of gene expression.
DISCUSSION
We have shown that changes in the activity of the histone
acetyl-transferase Kat2a deplete a significant proportion of
H3K9 acetylation sites at promoter locations and alter gene
expression heterogeneity in mouse ES cells. Affected loci
include key components of the pluripotency network, as well
as general metabolic categories, which suggests that this mode
of action may be extended to other cell types and develop-
mental contexts. We have estimated heterogeneity on the
basis of expression level CV and shown that Kat2a-inhibited
cultures exhibited higher CVs than controls, particularly when
probed from naïve (2i) pluripotency conditions. Functionally,
this translated into a curtailed ability to establish naïve pluri-
potency and an increased propensity to initiate ME differentia-


























































































































































































































































































































































































































































































































































































































































































































































































Figure 6. MB-3 treatment of TNGA mouse embryonic stem cells results in increased transcriptional heterogeneity from key pluripotency
and differentiation regulatory loci. (A): T-distributed stochastic neighbor embedding (t-SNE) plot of transcriptional profiles of individual
TNGA cells treated with DMSO or MB-3 in ESLIF and 2i conditions. (B): Overall changes in gene expression squared coefficient of variation
between DMSO and MB-3-treated cells assayed from ESLIF (left) and 2i (right) culture conditions (paired Student’s t test, p < .0001). (C):
Ordered representation of gene expression changes between DMSO and MB-3-treated TNGA cells in ESLIF (top) and 2i (bottom) conditions.
Mean expression represented as dot, standard error of the mean is represented as vertical bars. Abbreviation: DMSO, dimethyl sulfoxide.
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exit the pluripotent state, without accompanying changes in
cell cycle or apoptosis. Our recent report that loss of KAT2A
can promote differentiation of human leukemic cells [20] is
compatible with a generalization of the principles established
in this work.
Notably, the radical changes observed upon MB-3 treat-
ment occur with minimal perturbation of average gene expres-
sion levels, sustaining the notion that variability of gene
expression can, in itself, alter the probability of state transi-
tions of individual cells. This is compatible with our previous
observations in the hematopoietic system that lineage specifi-
cation can be consequent to distinct individual molecular
events, which are stochastic in nature and independently drive
reorganization of transcriptional programs [9]. Indeed, in
mouse ES cells treated with MB-3 and sampled from a newly
established naïve pluripotency state, transcriptional heteroge-
neity resulted in a dramatic reconfiguration of GRNs, with
destabilization of Pou5f1/Oct4 connectivity, as well as of other
transcriptional and signaling regulators of pluripotency, includ-
ing transcriptional and cell–cell adhesion components of the
Wnt pathway. Furthermore, GRN remodeling observed upon
Kat2a inhibition included novel associations suggestive of dif-
ferentiation, but also concomitant nucleation of the networks
by Nanog, likely denoting the capture of an early and normally
transient state in which differentiation programs are primed in
the context of a subsisting pluripotency network. Although it
was not based on known interactions, our experimental and
modeling data lend support to this interpretation.
The underlying transcriptional variability that accompanies
capture of the MN transition state is reminiscent of other tran-
sition events associated with enhanced heterogeneity
[2, 3, 5, 7]. Recently, it was suggested that heterogeneity of
expression levels occurs primarily in genes which decrease
their expression at fate decisions [36] but that this heteroge-
neity resolves on commitment to a stable, differentiated state,
requiring a dynamic means of transcriptional regulation. In line
with this view, Ahrends et al. [1] have modeled the contribu-
tion of transcriptional noise during commitment and progres-
sion and adipocyte differentiation and found that while low
levels of noise ensure lineage commitment, noise must be lim-
ited for differentiation to progress. Lysine acetylation is a
highly dynamic post-translational modification, and selective
perturbation of H3K9 acetylation constitutes an interesting
regulatory paradigm, as it associates with maintenance, but
not with initiation, of transcriptional activity [37]. As such,
reduction in H3K9 acetylation at specific loci is likely to desta-
bilize, but not abolish, the transcriptional processes, and result
in stochastic gene expression, on which other more stable epi-
genetic marks can act. At a molecular level, our results mirror
the effects of the yeast Kat2a homolog Gcn5 on transcriptional
noise [18, 34], and thus suggest that in eukaryotes, H3K9 acet-
ylation may play a central role in the control of heterogeneity.
Our observations also suggest that dynamic control of tran-
scriptional noise may be key to efficient state transitions.
Early reports on Kat2a null mouse ES cells did not indicate




























































































Figure 7. Network analysis of MB-3-treated cells shows destabilization following Kat2a inhibition. (A): Association network diagrams of
Kat2a-dependent H3K9ac target genes upon DMSO and MB-3 treatment. Square nodes, Kat2a-dependent H3K9ac target genes; white
nodes, correlated genes; edge color, correlation observation in each condition (black = common; blue = DMSO only, green = MB-3 only).
(B): Enumeration of total network edges centered on Kat2a-dependent H3K9ac target and nontarget genes upon treatment of TNGA
embryonic stem (ES) cells in 2i with either DMSO or MB-3. (C): Coefficient of variation (CV) gain [(CVMB-3-CVDMSO)/CVDMSO] for DMSO
unique, MB-3 unique, and common edges in the remodeled networks centered on Kat2a-dependent H3K9ac targets (shown in A and B).
(D): CV gain in network nodes exclusively present in DMSO or MB-3 treatment of TNGA ES cells in 2i. All analyses used paired Student’s
t test. Abbreviation: DMSO, dimethyl sulfoxide.
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However, they did denote an acceleration of differentiation of
embryoid bodies, and reduced contribution to chimaeras, both
of which are compatible with our observed destabilization of
pluripotency and anticipation of early ME differentiation, as
well as with the proposition that persistent high noise levels
prevent terminal execution of lineage programs. Indeed,
Kat2a-null embryoid bodies, particularly in a conditional knock-
out framework, constitute a good system in which to test the
contribution of gene expression heterogeneity at different
stages of differentiation progression, and in different lineages.
Recent detailed analysis of the molecular pathways underlying
the Kat2a null defects in embryoid bodies [27] identified an
association with general metabolic pathways, which we also
see in our work, and a specific defect in Fgf signaling. Although
Fgf signaling is actively repressed in our experimental context,
it is noteworthy that Fgfr1 is a direct target of Kat2a-mediated
H3K9 acetylation, and that Fgf4 and Fgfr1 exhibit reduced net-
work connectivity and increased variability of gene expression
upon MB-3 treatment.
Finally, it should be noted that we conducted the molecular
analyses using MB-3 chemical inhibition of Kat2a at fairly high
concentration which has known limitations [39]; however, we
were able to validate the cellular consequences of Kat2a inhibi-
tion with gene expression knockdown, suggesting that the
observed results are biologically specific to Kat2a. We also used
various mouse ES cell lines, including TNGA cells that allow for
the direct exclusion of committed cells and the verification of
increased culture heterogeneity by a simple measure. TNGA are
heterozygous for Nanog, and consequently partially defective
for the autoregulatory loop that maintains Nanog expression
[16] and re-enforces pluripotency. The loss or inhibition of Kat2a
in these cells may be sufficient to affect the metastability of the
primed pluripotency state and enhance heterogeneity. The
reproducibility of cellular events in non-TNGA cells suggests a
more universal mechanism of noise enhancement, but this may
need to be experimentally validated in other ES cell lines, and
distinct cell types. Along the same line, it will be interesting to
test whether other epigenetic regulators suggested to regulate
transcriptional noise in yeast [18] have a similar impact on exit
from pluripotency, or if sequence editing of locus-specific regu-
latory elements targeted by H3K9 acetylation promotes exit
from pluripotency in wild-type mouse ES cells. The recent dem-
onstration that locus-specific editing of promoter acetylation
alters the frequency of transcriptional bursting [40], which may
in turn modify transcriptional noise [18], supports the feasibility
of the proposed approaches. The on-going expansion of CRISPR-
based tools for gene and epigenetic editing [41] should further
assist in these experiments and provide an invaluable resource
for dissection of cell state transitions in multiple stem cell sys-
tems and during development.
CONCLUSION
In summary, we use Kat2a inhibition in mouse ES cells to
establish a relationship between transcriptional heterogeneity
and cell fate transitions, through manipulation of promoter
acetylation and with destabilization of underlying transcrip-
tional networks. This relationship may extend to other normal
and malignant stem cell systems.
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